| Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle Y Dekempeneer, M Keyaerts, A Krasniqi, J Puttemans, S Muyldermans, ... Expert opinion on biological therapy 16 (8), 1035-1047, 2016 | 155 | 2016 |
| Same-day imaging using small proteins: clinical experience and translational prospects in oncology A Krasniqi, M D’Huyvetter, N Devoogdt, FY Frejd, J Sörensen, A Orlova, ... Journal of Nuclear Medicine 59 (6), 885-891, 2018 | 124 | 2018 |
| Theranostic radiolabeled anti-CD20 sdAb for targeted radionuclide therapy of non-Hodgkin lymphoma A Krasniqi, M D'Huyvetter, C Xavier, K Van der Jeught, S Muyldermans, ... Molecular cancer therapeutics 16 (12), 2828-2839, 2017 | 74 | 2017 |
| Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix) AC Guardo, PT Joe, L Miralles, ME Bargalló, B Mothe, A Krasniqi, ... Aids 31 (3), 321-332, 2017 | 47 | 2017 |
| Evaluation of [99mTc]Radiolabeled Macrophage Mannose Receptor-Specific Nanobodies for Targeting of Atherosclerotic Lesions in Mice G Bala, H Baudhuin, I Remory, K Gillis, P Debie, A Krasniqi, T Lahoutte, ... Molecular Imaging and Biology 20, 260-267, 2018 | 28 | 2018 |
| Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors E Bolli, M D’Huyvetter, A Murgaski, D Berus, G Stangé, EJ Clappaert, ... Journal of controlled release 314, 1-11, 2019 | 26 | 2019 |
| Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20 A Krasniqi, M Bialkowska, C Xavier, K Van der Jeught, S Muyldermans, ... New biotechnology 45, 69-79, 2018 | 22 | 2018 |
| Identification of nanobodies against the acute myeloid leukemia marker CD33 E Romão, A Krasniqi, L Maes, C Vandenbrande, YGJ Sterckx, ... International journal of molecular sciences 21 (1), 310, 2020 | 18 | 2020 |
| A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma E Duray, M Lejeune, F Baron, Y Beguin, N Devoogdt, A Krasniqi, ... Journal of hematology & oncology 14, 1-13, 2021 | 15 | 2021 |
| Emerging applications of nanobodies in cancer therapy RM Awad, F Meeus, H Ceuppens, T Ertveldt, H Hanssens, Q Lecocq, ... International review of cell and molecular biology 369, 143-199, 2022 | 14 | 2022 |
| CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma K De Veirman, J Puttemans, A Krasniqi, T Ertveldt, H Hanssens, E Romao, ... Oncoimmunology 10 (1), 2000699, 2021 | 10 | 2021 |
| Targeted radionuclide therapy with low and high-dose lutetium-177–labeled single domain antibodies induces distinct immune signatures in a mouse melanoma model T Ertveldt, L De Beck, K De Ridder, H Locy, W De Mey, C Goyvaerts, ... Molecular Cancer Therapeutics 21 (7), 1136-1148, 2022 | 6 | 2022 |
| Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor … T Ertveldt, A Krasniqi, H Ceuppens, J Puttemans, Y Dekempeneer, ... Journal of Nuclear Medicine 64 (5), 751-758, 2023 | 5 | 2023 |
| Radiotheranostic agents in hematological malignancies J Caers, E Duray, L Vrancken, G Marcion, V Bocuzzi, K De Veirman, ... Frontiers in Immunology 13, 911080, 2022 | 5 | 2022 |
| Newer Bioconjugation Methods A Krasniqi, C Xavier, N Devoogdt Molecular Imaging, 517-529, 2021 | 1 | 2021 |
| Accepted poster session at ImmunoRad 2023: Targeted alpha therapy using Actinium-225 radiolabeled single domain antibodies induces antigen-specific immune responses and … T Ertveldt, A Krasniqi, H Ceuppens, J Puttemans, Y Dekempeneer, ... ImmunoRad 2023: The International Conference on Immunotherapy Radiotherapy …, 2023 | | 2023 |
| Targeted alpha therapy using Actinium-225 radiolabeled single domain antibodies induces antigen-specific immune responses and instills immunomodulation both systemically and at … T Ertveldt, K Breckpot, N Devoogdt, J Puttemans, K De Veirman, ... | | 2022 |
| The therapeutic potential of Actinium-225-labeled CS1-specific single-domain antibodies for the treatment of Multiple Myeloma K De Veirman, J Puttemans, A Krasniqi, H Hanssens, E Romao, ... Nanobodies: Hybrid 2nd edition-VIB, 2021 | | 2021 |
| Investigating immune activation upon beta targeted radionuclide therapy using anti-CD20 single domain antibody fragments in melanoma T Ertveldt, Y Dekempeneer, L De Beck, C Goyvaerts, Q Lecocq, ... BACR Annual Meeting 2020: Cancer metastasis: From bedside to bench, 2020 | | 2020 |
| Moleculaire beeldvorming met radioactief gemerkte nanobodies A Krasniqi SCOOP symposium 2019, Vereniging van Medisch Beeldvormers, 2019 | | 2019 |
